原著論文・総説

​SMTP-44D alleviates diabetic retinopathy by suppressing inflammation and oxidative stress in in vivo and in vitro models.
Ishibashi M., Shibata K., Terasaki M., Saito Y., Yamagishi S., Hasumi K., Nobe K.

(J Pharmacol Sci, 157, 57-64, 2025.)

​​

​​

学会発表

​

​

​

​

​